The use of genetically engineered cells in drug discovery.
Boehringer Ingelheim R&D Vienna, Bender & Co., Austria.
G
G
Loeber
R
R
Schnitzer
D000818:Animals; D000998:Antiviral Agents; D001709:Biotechnology / Q000379:methods*; D002460:Cell Line; D015195:Drug Design; D004345:Drug Industry; D004791:Enzyme Inhibitors; D005818:Genetic Engineering / Q000379:methods*; D006801:Humans; D020794:Receptor Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors
D000998:Antiviral Agents; D004791:Enzyme Inhibitors; D020794:Receptor Protein-Tyrosine Kinases